» Articles » PMID: 35330316

Clinical Presentations, Cluster Analysis and Laboratory-Based Investigation of Otomycosis-A Single Center Experience

Abstract

Species of () complex and complex are predominant molds that are causative agents of otomycoses. The goal of this study was to investigate the clinical presentation, diagnostic procedure, and appearance of relapse in patients with -otomycosis, as well as to determine the biofilm production ability of species isolated in relapse. Thirty patients with laboratory evidenced -otomycosis followed by two check-ups (30 and 60 days after initiation of treatment with antimycotics for local application) were included in the study. For isolation and identification of spp. the standard mycological procedure was applied. Results showed very high sensitivity of microscopy, but 16.7% species required the optimal temperature of 27-28 °C for cultivation. Applied statistical cluster analysis showed a defined specific cluster/group of patients with complex-otomycosis. Sixty days after diagnosis and treatment initiation, six patients had a relapse, with the same species of genus being the cause. To establish the ability of biofilm production, the modified method described by Pierce and Kvasničková was performed, and all six species isolated in the relapse episode had the ability to produce biofilm. Official criteria and recommendations are needed due to the possibility of misdiagnosis, which leads to the prolongation and complication of the disease.

Citing Articles

Study on the microbial diversity of ear canal secretions from patients with otomycosis.

Chen Z, Zhao Z Front Surg. 2024; 11:1277799.

PMID: 38450054 PMC: 10916698. DOI: 10.3389/fsurg.2024.1277799.


Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review.

Bojanovic M, Stalevic M, Arsic-Arsenijevic V, Ignjatovic A, Randelovic M, Golubovic M J Fungi (Basel). 2023; 9(6).

PMID: 37367598 PMC: 10302809. DOI: 10.3390/jof9060662.


Relapsing otomycosis despite prolonged systemic antifungal therapy and resolution after topical voriconazole administration: A case report.

Wee L, Tan M, Tan A, Tang J Med Mycol Case Rep. 2023; 39:23-25.

PMID: 36632528 PMC: 9826810. DOI: 10.1016/j.mmcr.2022.12.006.


Poly-(lactic--glycolic) Acid Nanoparticles Entrapping Pterostilbene for Targeting Section .

Orekhova A, Palocci C, Chronopoulou L, De Angelis G, Badiali C, Petruccelli V Molecules. 2022; 27(17).

PMID: 36080191 PMC: 9458066. DOI: 10.3390/molecules27175424.

References
1.
Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I . Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007; 115(8):891-9. DOI: 10.1111/j.1600-0463.2007.apm_630.x. View

2.
Pierce C, Uppuluri P, Tristan A, Wormley Jr F, Mowat E, Ramage G . A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008; 3(9):1494-500. PMC: 2741160. DOI: 10.1038/nport.2008.141. View

3.
Kryukov A, Kunelskaya N, Kunelskaya V, Ivoilov A, Turovskiy A, Shadrin G . [Otomycosis: the modern view of etiology and management]. Vestn Otorinolaringol. 2018; 83(1):48-51. DOI: 10.17116/otorino201883148-51. View

4.
Rawson T, Fatania N, Abdolrasouli A . UK standards for microbiology investigations of ear infection (SMI B1) are inadequate for the recovery of fungal pathogens and laboratory diagnosis of otomycosis: A real-life prospective evaluation. Mycoses. 2022; 65(4):490-495. DOI: 10.1111/myc.13423. View

5.
Kvasnickova E, Paulicek V, Paldrychova M, Jezdik R, Matatkova O, Masak J . Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid. World J Microbiol Biotechnol. 2016; 32(11):187. DOI: 10.1007/s11274-016-2146-9. View